Dimethyl fumarate
Generic name: Dimethyl Fumarate
Dosage form: oral delayed release capsule (-; 120 mg; 240 mg)
Drug class:
Selective immunosuppressants
Usage of Dimethyl fumarate
Dimethyl fumarate is used to treat relapsing forms of multiple sclerosis in adults (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease).
Dimethyl fumarate may also be used for purposes not listed in this medication guide.
Dimethyl fumarate side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Dimethyl fumarate may cause a serious brain infection that can lead to disability or death. Call your doctor right away if you have problems with speech, thought, vision, or muscle movement. These symptoms may start gradually and get worse quickly.
Also call your doctor at once if you have:
Common side effects of dimethyl fumarate may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Dimethyl fumarate
You should not use dimethyl fumarate if you have had a severe allergic reaction to dimethyl fumarate or diroximel fumarate (Vumerity).
Tell your doctor if you have ever had:
Tell your doctor if you are pregnant or breastfeeding.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of dimethyl fumarate on the baby.
Dimethyl fumarate is not approved for use by anyone younger than 18 years old.
Relate drugs
- Abrocitinib
- Alefacept
- Amevive
- Anifrolumab
- Anifrolumab-fnia
- Anti-thymocyte globulin rabbit
- Atgam equine
- Aubagio
- Avacopan
- Muromonab-cd3
- Mycophenolate (Intravenous)
- Mycophenolate mofetil
- Mycophenolate mofetil oral/injection
- Mycophenolic acid
- Myfortic
- Bafiertam
- Belatacept
- Belimumab
- Belumosudil
- Benlysta
- Cellcept
- Cellcept (Mycophenolate Intravenous)
- Cellcept (Mycophenolate mofetil Oral)
- Cibinqo
- Dimethyl fumarate
- Diroximel fumarate
- Eculizumab
- Emapalumab
- Emapalumab-lzsg
- Empaveli
- Enjaymo
- Entyvio
- Fingolimod
- Gamifant
- Gilenya
- Inebilizumab
- Inebilizumab-cdon
- Lymphocyte immune globulin, anti-thymocyte equine
- Mayzent
- Monomethyl fumarate
- Natalizumab
- Natalizumab-sztn
- Nulojix
- Omalizumab
- Orthoclone OKT 3
- Ozanimod
- Pegcetacoplan
- Pegcetacoplan (Subcutaneous)
- Ponesimod
- Ponvory
- Ponvory Starter Pack
- Pozelimab-bbfg
- Raptiva
- Ravulizumab
- Ravulizumab-cwvz
- Rezurock
- Saphnelo
- Siponimod
- Soliris
- Sutimlimab
- Sutimlimab-jome
- Tascenso ODT
- Tavneos
- Tecfidera
- Teriflunomide
- Tezepelumab
- Tezepelumab-ekko
- Tezspire
- Tezspire Pre-filled Pen
- Tezspire Pre-filled Syringe
- Thymoglobulin
- Thymoglobulin rabbit
- Tyruko
- Tyruko (Natalizumab Intravenous)
- Tyruko (Natalizumab-sztn Intravenous)
- Tysabri
- Ultomiris
- Uplizna
- Vedolizumab
- Veopoz
- Vumerity
- Xolair
- Zeposia
How to use Dimethyl fumarate
Usual Adult Dose for Multiple Sclerosis:
Initial dose: 120 mg orally twice a day for 7 daysMaintenance dose: 240 mg orally twice a dayUse: For the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease
Warnings
Dimethyl fumarate may cause a serious brain infection that can lead to disability or death. Call your doctor right away if you have problems with speech, thought, vision, or muscle movement. These symptoms may start gradually and get worse quickly.
What other drugs will affect Dimethyl fumarate
Other drugs may affect dimethyl fumarate, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions